menu

CME: Poly-L-Lactic Acid: Best Microinjection Practices for Achieving Optimal Results

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Poly-L-Lactic Acid: Best Microinjection Practices for Achieving Optimal Results

Poly-L-Lactic Acid: Best Microinjection Practices for Achieving Optimal Results
RestartResume
With the appropriate use of PLLA, you can give your patients a more natural and three-dimensional, rejuvenated look. Here’s how.

Available credits: 1.00

Time to complete: 60 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Using Poly-L Lactic Acid (PLLA/Sculptra®Aesthetic) gives you the ability to enhance your patients’ facial volume—but only when done correctly. Here to review the best practices for using PLLA on the most common areas of the face are Dr. Sabrina Fabi and Dr. Rebecca Fitzgerald.

    Disclaimer: The list of available dermal fillers is continuously evolving. Since this activity was produced, some products are no longer approved by the US FDA or currently marketed, while others have received regulatory approval.  Providers are highly encouraged to click on this link to view the FDA’s updated list of injectable available: Dermal Fillers Approved by the Center for Devices and Radiological Health.

     

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Sabrina Fabi, MD, FAAD, FAACS has disclosed the following relevant financial relationships:  Served as an advisor or consultant for: Valeant, Galderma, Allergan, MerzServed as a speaker or a member of a speakers bureau for: Galderma, Allergan, Merz.

    Rebecca Fitzgerald, MD, FAAD, ASDS has disclosed the following relevant financial relationships:  Served as an advisor or consultant for: Allergan, Galderma, Merz.

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither Omnia Education nor TOPEC recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Omnia Education or TOPEC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

     Reviewers/Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Jason D. Bloom, MD receives consulting fees from Allergan, Aqua Pharmaceuticals, Cearna/OcuMend, Endo Pharmaceuticals, Galderma, InMode, MEND Nutrition, Merz, Remedly, Revance, RightResult, Sinclair, and ThermiAesthetics; is a speaker for Allergan, Alma Lasers, Galderma, InMode, Merz, and ThermiAesthetics; conducts contracted research with Allergan, Galderma, and Zeltiq; and has ownership interest in Cearna/OcuMend, MEND Nutrition, and Remedly.
    • Ken Brown has nothing to disclose.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Kia K. Gray, MPH has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
    • Jennifer Spear Smith, PhD has nothing to disclose.
  • Learning Objectives

    After completing this activity, participants should be better able to:

    • Describe the uniqueness of PLLA compared with other dermal fillers
    • Recite adverse events for filler injections and establish a clinic-wide plan to handle adverse events
    • Decide on the best PLLA reconstitution methods for your clinic
    • Identify the best PLLA candidates for the injection sites demonstrated
    • Integrate into practice using PLLA into the most common areas of the face
  • Target Audience

    This activity is designed to meet the educational needs of dermatologists, plastic surgeons and aesthetic health care professionals including nurse practitioners, nurses, physician assistants, OB/GYNs, and dentists throughout the U.S who have experience injecting fillers and Poly-L-Lactic Acid.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by an independent educational grant from Galderma USA.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.